Abra is a digital asset financial platform that enables consumers and institutions to buy, sell, store, and borrow against cryptocurrencies while generating yield through collateralized credit lines and structured loans. By providing a secure environment for trading and wealth management, Abra addresses the need for efficient liquidity and investment strategies in the rapidly evolving digital asset market.

ER Ocean Recherche creates marine‑derived textile materials such as SeiFibre™, SeiYarn™ and SeiShell™ by converting algae, cyanobacteria and seafood shell waste into fibers, yarns and coatings. Their low‑impact, plastic‑free process delivers high‑performance, scalable fabrics that are validated as finished garments for fashion brands, while supporting blue‑carbon initiatives and open collaboration with textile manufacturers.

Gro develops autonomous protocols for decentralized finance (DeFi) that simplify user interactions and enhance accessibility. By streamlining complex transactions, Gro addresses the barriers to entry for users unfamiliar with traditional DeFi platforms.

Kraftwerk develops solid oxide fuel cells (aSOFCs) that convert hydrogen and common e-fuels into electrical energy, providing a robust and cost-effective alternative to traditional combustion processes. Their technology addresses the inefficiencies of conventional energy generation by offering high system efficiency and rapid startup capabilities for various applications, including transportation and stationary power systems.

Limit offers a digital platform that provides instant quoting and binding for commercial insurance, connecting agents with over 50 carriers through its wholesale division. The technology minimizes administrative delays and errors, enabling agents to close deals faster and access comprehensive market insights.

Provides a shared progress tracking platform for coaches and clients, enabling clients to log actions, track goals, and maintain accountability between sessions. Coaches gain measurable insights into client progress and engagement through customizable logs, reminders, and real-time feedback tools, improving the effectiveness of their practice.

MiRus develops medical implants using a proprietary Molybdenum-Rhenium alloy, MoRe®, which offers superior strength, fatigue resistance, and biocompatibility compared to traditional materials. The company addresses the challenges of spinal and orthopedic degeneration by providing smaller, more durable implants and less invasive surgical solutions that enhance patient outcomes throughout the care continuum.

Ric is a weather monitoring platform that provides affordable flood risk assessment and management solutions. By utilizing real-time meteorological data, it enables users to make informed decisions to mitigate potential flood impacts on their properties.

SELECT is a Snowflake management platform that provides detailed visibility into usage and cost drivers, enabling users to identify inefficiencies at the workload level. By automating warehouse optimization, SELECT helps organizations reduce their Snowflake expenses by 10-20% without manual intervention.

This platform centralizes the job search process by offering personalized job matching and application management tools. Users benefit from an AI resume builder that tailors documents to specific job descriptions and an extension that autofills applications across various boards. The service also includes a comprehensive job tracker to monitor application status and streamline the entire hiring workflow.

Provides a business intelligence platform that analyzes operational processes to quantify manual time, repeatability, and costs. This data-driven approach helps organizations identify and prioritize areas for efficiency improvements, enabling targeted investments in process optimization.

Vironexis develops off-the-shelf T-cell immuno-gene therapies using its TransJoin™ AAV Gene Therapy Platform. This approach delivers a single-dose treatment designed to redirect T cells for durable, steady-state tumor killing without custom manufacturing. The company is advancing a pipeline of candidates targeting blood-based cancers, solid tumor metastasis prevention, and cancer vaccines.